Effectiveness of zoster vaccine in patients with chronic kidney disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20160607003

Enrollment

110

Registered

2016-06-07

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney diseases chronic kidney diseases zoster vaccine

Interventions

patients received zoster vaccine,patients do not receive zoster vaccine

Prevention,Prevention

zoster vaccine,control

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Chronic kidney disease stage 3 - 5

Exclusion criteria

Exclusion criteria: 1. Allergic to zoster vaccine

Design outcomes

Primary

Measure	Time frame
incidence of herpes zoster 3 years vaccine efficacy	—

Secondary

Measure	Time frame
postherpetic neuralgia 3 vaccine efficacy	—

Countries

Thailand

Contacts

Public ContactRatima Samorn

Queensaovabha Memorial Institute

ratima.s@redcross.or.th02-2520161

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026